Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
ALT
ALT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ALT ETF News Today | Earnings, Events & Price Alerts
ALT News
Altimmune to Participate in Multiple Investor Conferences
2d ago
Newsfilter
Analysis of Weight Loss Drug Market Prospects
5d ago
Fool
Altimmune to Report Q4 2025 Financial Results on March 5
6d ago
Newsfilter
Eli Lilly's Dominance in Obesity Drug Market Reinforced
Feb 23 2026
CNBC
Altimmune Receives Buy Rating from Analysts Amid Promising Drug Trials
Feb 18 2026
Yahoo Finance
Altimmune Closes Direct Offering of 17 Million Shares Raising $75 Million
Jan 29 2026
Newsfilter
Longevity Infrastructure Market Undergoes Structural Reset
Jan 29 2026
PRnewswire
Global Capital Shifts to Longevity Infrastructure Valued at $27 Trillion
Jan 29 2026
Newsfilter
Altimmune Announces $75 Million Stock Offering Amid Market Volatility
Jan 28 2026
Benzinga
Qorvo Shares Drop After Disappointing Earnings Guidance
Jan 28 2026
Benzinga
F5, Inc. Reports Strong Q1 Results and Raises FY26 Guidance
Jan 28 2026
Benzinga
Wall Street Optimistic Ahead of Fed Policy Decision
Jan 28 2026
stocktwits
Altimmune Secures $75M from Institutional Investor in Direct Offering
Jan 28 2026
seekingalpha
Altimmune Raises $75 Million to Fund MASH Trial Preparations
Jan 28 2026
stocktwits
Booz Allen Hamilton Q3 Earnings Beat Estimates, Shares Up 9.8%
Jan 23 2026
Benzinga
U.S. Government Requests Backup Power from Data Centers Amid Record Winter Storm
Jan 23 2026
stocktwits
Show More News
